NO751753L - - Google Patents
Info
- Publication number
- NO751753L NO751753L NO751753A NO751753A NO751753L NO 751753 L NO751753 L NO 751753L NO 751753 A NO751753 A NO 751753A NO 751753 A NO751753 A NO 751753A NO 751753 L NO751753 L NO 751753L
- Authority
- NO
- Norway
- Prior art keywords
- methylstyrene
- propanol
- butylphenyl
- analysis
- found
- Prior art date
Links
- -1 aralkyl hydrocarbons Chemical class 0.000 claims description 36
- 238000000034 method Methods 0.000 claims description 9
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 229930195733 hydrocarbon Natural products 0.000 claims description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N isopropyl alcohol Natural products CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 3
- 229960004592 isopropanol Drugs 0.000 claims 1
- 125000000555 isopropenyl group Chemical group [H]\C([H])=C(\*)C([H])([H])[H] 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 description 13
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- 238000009835 boiling Methods 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Chemical compound CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- UXMYYKOIANVGEH-UHFFFAOYSA-N 1-butan-2-yl-4-prop-1-en-2-ylbenzene Chemical compound CCC(C)C1=CC=C(C(C)=C)C=C1 UXMYYKOIANVGEH-UHFFFAOYSA-N 0.000 description 2
- NZGHJIGCMVGJTF-UHFFFAOYSA-N 1-cyclohexyl-4-prop-1-en-2-ylbenzene Chemical compound C1=CC(C(=C)C)=CC=C1C1CCCCC1 NZGHJIGCMVGJTF-UHFFFAOYSA-N 0.000 description 2
- GPDATMGCLOLJBJ-UHFFFAOYSA-N 1-fluoro-4-(4-prop-1-en-2-ylphenyl)benzene Chemical compound CC(=C)C1=CC=C(C=C1)C1=CC=C(F)C=C1 GPDATMGCLOLJBJ-UHFFFAOYSA-N 0.000 description 2
- KWSHGRJUSUJPQD-UHFFFAOYSA-N 1-phenyl-4-propan-2-ylbenzene Chemical group C1=CC(C(C)C)=CC=C1C1=CC=CC=C1 KWSHGRJUSUJPQD-UHFFFAOYSA-N 0.000 description 2
- PAMLTMDKARKMOU-UHFFFAOYSA-N 2-(3-methoxy-4-phenoxyphenyl)propan-2-ol Chemical compound COC=1C=C(C=CC1OC1=CC=CC=C1)C(C)(C)O PAMLTMDKARKMOU-UHFFFAOYSA-N 0.000 description 2
- QGTWZWNRBIVNML-UHFFFAOYSA-N 2-(3-phenylsulfanylphenyl)propan-2-ol Chemical compound C1(=CC=CC=C1)SC=1C=C(C=CC1)C(C)(C)O QGTWZWNRBIVNML-UHFFFAOYSA-N 0.000 description 2
- UQAXVZHQNKDTRP-UHFFFAOYSA-N 2-(4-butan-2-ylphenyl)propan-2-ol Chemical compound CCC(C)C1=CC=C(C(C)(C)O)C=C1 UQAXVZHQNKDTRP-UHFFFAOYSA-N 0.000 description 2
- JDYOGRRUTFRBDL-UHFFFAOYSA-N 2-(4-cyclohexylphenyl)propan-2-ol Chemical compound C1=CC(C(C)(O)C)=CC=C1C1CCCCC1 JDYOGRRUTFRBDL-UHFFFAOYSA-N 0.000 description 2
- GOKGIYHIVSGXDM-UHFFFAOYSA-N 2-(4-phenylphenyl)propan-2-ol Chemical compound C1=CC(C(C)(O)C)=CC=C1C1=CC=CC=C1 GOKGIYHIVSGXDM-UHFFFAOYSA-N 0.000 description 2
- SNGCLGKSXXZQGH-UHFFFAOYSA-N 2-(4-phenylsulfanylphenyl)propan-2-ol Chemical compound C1(=CC=CC=C1)SC1=CC=C(C=C1)C(C)(C)O SNGCLGKSXXZQGH-UHFFFAOYSA-N 0.000 description 2
- OHITVHATOPWRRY-UHFFFAOYSA-N 2-[4-(2-methylpropyl)phenyl]propan-2-ol Chemical compound CC(C)CC1=CC=C(C(C)(C)O)C=C1 OHITVHATOPWRRY-UHFFFAOYSA-N 0.000 description 2
- SFJJGLUATPUIGV-UHFFFAOYSA-N 2-methoxy-1-phenoxy-4-prop-1-en-2-ylbenzene Chemical compound COC1=C(OC2=CC=CC=C2)C=CC(=C1)C(C)=C SFJJGLUATPUIGV-UHFFFAOYSA-N 0.000 description 2
- OSJLDCQZKGVESM-UHFFFAOYSA-N 2-methyl-1-phenoxy-4-prop-1-en-2-ylbenzene Chemical compound CC(=C)C1=CC(C)=C(OC2=CC=CC=C2)C=C1 OSJLDCQZKGVESM-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 239000007903 gelatin capsule Substances 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- MSDQNIRGPBARGC-UHFFFAOYSA-N 1-(4-cyclohexylphenyl)ethanone Chemical compound C1=CC(C(=O)C)=CC=C1C1CCCCC1 MSDQNIRGPBARGC-UHFFFAOYSA-N 0.000 description 1
- QCZZSANNLWPGEA-UHFFFAOYSA-N 1-(4-phenylphenyl)ethanone Chemical group C1=CC(C(=O)C)=CC=C1C1=CC=CC=C1 QCZZSANNLWPGEA-UHFFFAOYSA-N 0.000 description 1
- XUDYHODVSUXRPW-UHFFFAOYSA-N 1-(4-phenylsulfanylphenyl)ethanone Chemical compound C1=CC(C(=O)C)=CC=C1SC1=CC=CC=C1 XUDYHODVSUXRPW-UHFFFAOYSA-N 0.000 description 1
- KEAGRYYGYWZVPC-UHFFFAOYSA-N 1-[4-(2-methylpropyl)phenyl]ethanone Chemical compound CC(C)CC1=CC=C(C(C)=O)C=C1 KEAGRYYGYWZVPC-UHFFFAOYSA-N 0.000 description 1
- LGJJGWHKUXUJNR-UHFFFAOYSA-N 1-[4-(4-fluorophenyl)phenyl]ethanone Chemical group C1=CC(C(=O)C)=CC=C1C1=CC=C(F)C=C1 LGJJGWHKUXUJNR-UHFFFAOYSA-N 0.000 description 1
- RUYZJEIKQYLEGZ-UHFFFAOYSA-N 1-fluoro-4-phenylbenzene Chemical group C1=CC(F)=CC=C1C1=CC=CC=C1 RUYZJEIKQYLEGZ-UHFFFAOYSA-N 0.000 description 1
- GAWAUDBMPDYIKL-UHFFFAOYSA-N 1-phenoxy-3-prop-1-en-2-ylbenzene Chemical compound CC(=C)C1=CC=CC(OC=2C=CC=CC=2)=C1 GAWAUDBMPDYIKL-UHFFFAOYSA-N 0.000 description 1
- FXQJDGUGOZWQNL-UHFFFAOYSA-N 1-phenylsulfanyl-3-prop-1-en-2-ylbenzene Chemical compound C1(=CC=CC=C1)SC=1C=C(C=CC1)C(=C)C FXQJDGUGOZWQNL-UHFFFAOYSA-N 0.000 description 1
- YNEGVEGBQYYYNY-UHFFFAOYSA-N 1-phenylsulfanyl-4-prop-1-en-2-ylbenzene Chemical compound CC(=C)C1=CC=C(SC2=CC=CC=C2)C=C1 YNEGVEGBQYYYNY-UHFFFAOYSA-N 0.000 description 1
- IXTMMFLDAGYLLL-UHFFFAOYSA-N 2-(3-phenoxyphenyl)propan-2-ol Chemical compound CC(C)(O)C1=CC=CC(OC=2C=CC=CC=2)=C1 IXTMMFLDAGYLLL-UHFFFAOYSA-N 0.000 description 1
- YQEYLXLAWZVDQO-UHFFFAOYSA-N 2-[2-(4-fluorophenyl)phenyl]propan-2-ol Chemical compound FC1=CC=C(C=C1)C1=C(C=CC=C1)C(C)(C)O YQEYLXLAWZVDQO-UHFFFAOYSA-N 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical class [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 239000007818 Grignard reagent Substances 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- XYLMUPLGERFSHI-UHFFFAOYSA-N alpha-Methylstyrene Chemical class CC(=C)C1=CC=CC=C1 XYLMUPLGERFSHI-UHFFFAOYSA-N 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 150000004795 grignard reagents Chemical class 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004968 inflammatory condition Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- CCERQOYLJJULMD-UHFFFAOYSA-M magnesium;carbanide;chloride Chemical compound [CH3-].[Mg+2].[Cl-] CCERQOYLJJULMD-UHFFFAOYSA-M 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 239000008024 pharmaceutical diluent Substances 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
Foreliggende oppfinnelse angår fremgangsmåter for fremstilling av nye aralkylhydrokarboner med følgende formel: The present invention relates to methods for the production of new aralkyl hydrocarbons with the following formula:
hvor Ar representerer 3-fenoksyfenyl, 3-fenyltiofenyl, 4-fenyltiofenyl, 4-cykloheksylfenyl, 4-iso-butylfenyl, 4-cykloheksyl-3-klor-fenyl, 4-fenoksy-3-metylfenyl, 4-fenoksy-3-metoksyfenyl, 4'-fluorbifenyl, 3-klor-4-allyloksyfenyl, 4-n-butylfenyl eller 4-sec-butylfenyl,karakterisert vedat man dehydrolyserer en iso-propanolforbindelse med formelen Ar - C (CH^)20H'hvor Ar er som definert ovenfor. where Ar represents 3-phenoxyphenyl, 3-phenylthiophenyl, 4-phenylthiophenyl, 4-cyclohexylphenyl, 4-iso-butylphenyl, 4-cyclohexyl-3-chloro-phenyl, 4-phenoxy-3-methylphenyl, 4-phenoxy-3-methoxyphenyl , 4'-fluorobiphenyl, 3-chloro-4-allyloxyphenyl, 4-n-butylphenyl or 4-sec-butylphenyl, characterized by dehydrolysing an isopropanol compound with the formula Ar - C (CH^)20H', where Ar is as defined above.
Man får tilveiebrakt en symptomatisk lindring av in-flammasjon av følgende svelling, sårhet og ømhet samt nedsatt be-vegelighet, smerte og feber når man tilfører fra 1 til 100 mg/kg kropsvekt daglig av en aralkylforbindelse som definert ovenfor, Symptomatic relief of inflammation of the following swelling, soreness and tenderness as well as reduced mobility, pain and fever is provided when one adds from 1 to 100 mg/kg body weight daily of an aralkyl compound as defined above,
til mennesker og dyr som lider av inflammatoriske tilstander, og denne tilførsel kan enten skje oralt eller parentralt. to humans and animals suffering from inflammatory conditions, and this administration can be either oral or parenteral.
Blant forbindelser som kan.brukes i foreliggende oppfinnelse er følgende: Among compounds that can be used in the present invention are the following:
3- fenoksy-a-metylstyren 3-phenoxy-α-methylstyrene
4- sib-butyl-a-metylstyren 4-sib-butyl-a-methylstyrene
3- fenyltio-a-metylstyren 3-phenylthio-α-methylstyrene
4- fenyltio-a-metylstyren 4- phenylthio-α-methylstyrene
4-cykloheksyl -a-metylstyren 4-cyclohexyl-α-methylstyrene
3- metyl-4-fenoksy-a-metylstyren 3- methyl-4-phenoxy-α-methylstyrene
4- n-butyl-a-metylstyren 4-n-butyl-a-methylstyrene
4-sec-butyl-a-metylstyren 4-sec-butyl-α-methylstyrene
1-(4-kumenyl)cykloo-ten 1-(4-cumenyl)cycloethene
4-(4-fluorfenyl)-a-metylstyren 4-(4-fluorophenyl)-α-methylstyrene
3-metoksy-4-fenoksy-a-metylstyren 3-Methoxy-4-phenoxy-α-methylstyrene
3-klor-4-allyloksy-a-metylstyren 3-chloro-4-allyloxy-α-methylstyrene
De forbindelser som anvendes i praksis i forbindelse med foreliggende oppfinnelse er utmerkede anti-inflammatoriske midler og er vanligvis fri fra de sideeffekter som opptrer i tarmkanalen som man ofte ser i forbindelse med andre kjente midler. Eksempler på slik anti-inflammatorisk aktivitet er gitt i den etterfølgende tabell. Oral ED^q uttryktti mg/kg av forbindel-sene ifølge foreliggende oppfinnelse er bestemt ved en erytem-bokkerende prøve utført slik det i alt vesentlig er beskrevet av Winder, CV. et al.Archives Int.Pharmacodym, vol. 116, side 261 The compounds used in practice in connection with the present invention are excellent anti-inflammatory agents and are usually free of the side effects that occur in the intestinal tract that are often seen in connection with other known agents. Examples of such anti-inflammatory activity are given in the following table. Oral ED^q expressed as ten mg/kg of the compounds according to the present invention is determined by an erythema-inducing test carried out essentially as described by Winder, CV. et al. Archives Int. Pharmacodym, vol. 116, page 261
(1958). Resultatene er vist i den følgende tabell. (1958). The results are shown in the following table.
Generelt er det slik at forbindelser som anvendes i foreliggende oppfinnelse vil kunne la seg fremstillé ved fremgangsmåter som i seg selv er kjente for fremstilling av aralkylhydrokarboner. De anvendte forbindelser kan fremstilles fra en passende arylkarboksylsyre eller acetofenon. In general, it is the case that compounds used in the present invention can be prepared by methods which are known in themselves for the production of aralkyl hydrocarbons. The compounds used can be prepared from a suitable arylcarboxylic acid or acetophenone.
Et annet aspekt ifølge foreliggende oppfinnelse angår farmasøytiske preparater i doseenhet som er tilpasset en oral eller parenteral tilførsel. Man oppnår ved dette en anti-inflammatorisk effekt. En anti-inflammatorisk effektiv og ikke-toksisk mengde vil ligge i området fra ca. 50 til ca. 1000 milligram av en forbindelse med formelen Another aspect according to the present invention relates to pharmaceutical preparations in dosage units which are adapted for oral or parenteral administration. This results in an anti-inflammatory effect. An anti-inflammatory effective and non-toxic amount will be in the range from approx. 50 to approx. 1000 milligrams of a compound of the formula
som denne er definert ovenfor, samt et farmasøytisk fortynnings-middel. Et foretrukket farmasøytisk preparat er ett som er tilpasset oral tilførsel og som vil kunne være myke gelatinkapsler, harde gelatinkapsler eller tabletter slik disse er illustrert nedenfor. En foretrukken forbindelse for tilførsel ifølge dette aspekt er 4-fenylkumen, men man kan også bruke andre forbindelser av den type som er angitt ovenfor som en erstatning for alt eller deler av nevnte,4-fenylkumen. as defined above, as well as a pharmaceutical diluent. A preferred pharmaceutical preparation is one which is suitable for oral administration and which could be soft gelatin capsules, hard gelatin capsules or tablets as illustrated below. A preferred compound for delivery according to this aspect is 4-phenylcumene, but one can also use other compounds of the type indicated above as a substitute for all or part of said 4-phenylcumene.
Ovennevnte forbindelser kan som sagt fremstilles ved fremgangsmåter som i seg selv er kjente. De følgende eksempler illustrerer fremgangsmåter som kan brukes for fremstilling av forbindelser som kan brukes i foreliggende oppfinnelse. The above-mentioned compounds can, as said, be produced by methods which are known per se. The following examples illustrate methods that can be used for the preparation of compounds that can be used in the present invention.
Eksempel 1. Example 1.
Fremstilling av 2-( 4- bifenylyl)- 2- propanoi. Preparation of 2-(4-biphenylyl)-2-propane.
En oppløsning av 98 g 4-acetylbifenyl oppløst i 500 ml eter og 500 ml benzen, ble dråpevis under røring tilsatt 500 ml av en 2,15 molar oppløsning av metylmagnesiumklorid som var blitt fortynnet med tilsvarende volumeter, og med slik hastighet at reak-sjonen kokte svakt under tilbakeløp. Etter at tilsetningen var full-stendig, ble blandingen kokt under tilbakeløp over natten. A solution of 98 g of 4-acetylbiphenyl dissolved in 500 ml of ether and 500 ml of benzene was added dropwise with stirring to 500 ml of a 2.15 molar solution of methylmagnesium chloride which had been diluted with corresponding volumes, and at such a rate that the reaction boiled gently under reflux. After the addition was complete, the mixture was refluxed overnight.
Blandingen ble så avkjølt til romtemperatur og over-skudd av nevnte Grignard-reagens ble dekomponert ved dråpevis til-setning av 178 ml av en mettet ammoniumklorid-oppløsning. Det organiske lag ble avhelt fra det resulterende uorganiske residum og så helt over i isvann. Det organiske lag ble utskilt, vasket med fortynnet natriumbikarbonat-oppløsning og vann og så tørket over natriumsulfat. Fordampning av oppløsningsmidlene i vakuum ga et hvitt fast residum som ble utkrystallisert fra heksan, hvorved man fikk 85 g 2-(4-bifenylyl)-2-propanol, smeltepunkt 88,5 - 90,5°C. Analyse, beregnet for C.-H--0: C, 84,87; H, 7,60. The mixture was then cooled to room temperature and the excess of said Grignard reagent was decomposed by the dropwise addition of 178 ml of a saturated ammonium chloride solution. The organic layer was decanted from the resulting inorganic residue and poured into ice water. The organic layer was separated, washed with dilute sodium bicarbonate solution and water and then dried over sodium sulfate. Evaporation of the solvents in vacuum gave a white solid residue which was crystallized from hexane, whereby 85 g of 2-(4-biphenylyl)-2-propanol were obtained, melting point 88.5 - 90.5°C. Analysis, calculated for C.-H--O: C, 84.87; H, 7.60.
lb lb lb lb
Funnet:. C, 85,01; H, 7,54. Found: C, 85.01; H, 7.54.
Denne forbindelse kan brukes for å fremstille 4-fenyl-a-metylstyren ved den fremgangsmåte som er angitt i eksempel 10. Eksemplene 2- 9. This compound can be used to prepare 4-phenyl-a-methylstyrene by the method indicated in example 10. Examples 2-9.
De følgende forbindelser ble fremstilt som angitt i eksempel 1, fra det tilsvarende acetofenon eller substituert benzo- atester, ved å bruke passende mengder av metylmagnesiumhalid-oppløsning: 2-(3-fenyltiofenyl)-2-propanol, kokepunkt, 154-156°/0,05 ram; The following compounds were prepared as indicated in Example 1, from the corresponding acetophenone or substituted benzoate ester, using appropriate amounts of methylmagnesium halide solution: 2-(3-phenylthiophenyl)-2-propanol, b.p. 154-156°/ 0.05 ram;
23 23
nD = 1,6132, fra 3-fenyltioacetofenon. nD = 1.6132, from 3-phenylthioacetophenone.
Analyse, beregnet for C15H160S; C, 73,72; H, 6,60; S, 13,12. Analysis, calculated for C15H160S; C, 73.72; H, 6.60; S, 13,12.
Funnet: C, 73,46; H, 6,63; S, 13,35. Found: C, 73.46; H, 6.63; S, 13.35.
2-(4-fenyltiofenyl)-2-propanol, kokepunkt, 144-153°C/0,09 mm; 2-(4-phenylthiophenyl)-2-propanol, bp, 144-153°C/0.09 mm;
25 25
nD =1,6154, fra 4-fenyltioacetofenon. nD =1.6154, from 4-phenylthioacetophenone.
Analyse, beregnet for C^H^OS: C, 73,72; H, 6,60; S, 13,12. Analysis, calcd for C 2 H 2 O 2 : C, 73.72; H, 6.60; S, 13,12.
Funnet: C, 73,99; H, 6,89! S, 12,91. 2-(4-iso-butylfenyl)-2-propanol, kokepunkt, 77-85°/0,16 mm; Found: C, 73.99; H, 6.89! S, 12.91. 2-(4-iso-butylphenyl)-2-propanol, bp, 77-85°/0.16 mm;
25 25
nD = 1,5050, fra 4-iso-butylacetofenon. nD = 1.5050, from 4-iso-butylacetophenone.
Analyse, beregnet for C13H20<0:>C, 81,20; H, 10,48 Analysis, calculated for C13H20<0:>C, 81.20; H, 10.48
Funnet: C, 80,97; H, 1052. Found: C, 80.97; H, 1052.
2-(4-sec-butylfenyl)-2-propanol, kokepunkt 73-80°/0,05 mm, 2-(4-sec-butylphenyl)-2-propanol, boiling point 73-80°/0.05 mm,
nD<23>=1,5094, fra 4-sec-butylacetofenon. nD<23>=1.5094, from 4-sec-butylacetophenone.
Analyse, beregnet for C13H2()0: C, 81,20; H,, 1048. Analysis, calcd for C13H2()0: C, 81.20; H,, 1048.
Funnet: C, 81,09; H, 10,71. 2-(4-cykloheksylfenyl)-2-propanol, smeltepunkt: 71-74 C, Found: C, 81.09; H, 10.71. 2-(4-cyclohexylphenyl)-2-propanol, melting point: 71-74 C,
fra 4-cykloheksylacetofenon. from 4-cyclohexylacetophenone.
Analyse, beregnet for C^H^O: C, 82,51; H, 10,16. Analysis, calcd for C 2 H 2 O: C, 82.51; H, 10,16.
Funnet: C, 82,49; H, 10,04. 2-(3-metoksy-4-fenoksyfenyl)-2-propanol, kokepunkt, 170-177 /0,07mmnD<25>=1,5762 fra 3-metoksy-4-fenoksy-acetofenon. Found: C, 82.49; H, 10.04. 2-(3-Methoxy-4-phenoxyphenyl)-2-propanol, bp, 170-177 /0.07mmnD<25>=1.5762 from 3-methoxy-4-phenoxy-acetophenone.
Analyse, beregnet for C16Hlg03: C,<74,39>; H, 7,02. Analysis, calculated for C 16 HlgO 3 : C,<74.39>; H, 7.02.
Funnet: C, 74,58; H, 7,29. 2-(3-met£5lL-4-fenoksyfenyl)-2-propanol, kokepunkt, 145-146°/0, 08 mm, n d 25=1,5705, fra 3-metyl-4-fenoksy-acetofenon. 2-(4'-fluorbifenylyl)-2-propanol, smeltepunkt, 110-111 , fra 4'-fluor-4-acetylbifenyl. Found: C, 74.58; H, 7.29. 2-(3-Methyl-4-phenoxyphenyl)-2-propanol, bp, 145-146°/0.08 mm, n d 25=1.5705, from 3-methyl-4-phenoxy-acetophenone. 2-(4'-fluorobiphenylyl)-2-propanol, m.p., 110-111 , from 4'-fluoro-4-acetylbiphenyl.
Analyse, beregnet for C15H15<F>O: C 78,24; H, 6,57 Analysis, calculated for C15H15<F>O: C 78.24; H, 6.57
Funnet: C,77,95; H, 6,79. Found: C, 77.95; H, 6.79.
Disse alkoholer ble omdannet til a-metylstyrener ved den fremgangsmåte som er angitt i eksempel 10. These alcohols were converted into α-methylstyrenes by the method indicated in example 10.
Eksempel 10. Example 10.
Fremstilling av 4- fenyl- a- metylstyren. Production of 4-phenyl-a-methylstyrene.
En suspensjon av 42,4 g 2-(4-bifenylyl)-2-propanol i 100 ml 4N svovelsyre og 50 ml etanol ble kokt under tilbakeløp og kraftig røring i 1.1/2 time. Deretter ble 50 ml etanol tilsatt, og blandingen ble kokt under tilbakeløp i ytterligere 2.1/2 time. Etter avkjøling til romtemperatur ble blandingen helt over i isvann og ekstrahert med eter, benzen og kloroform. De organiske ekstrakter ble slått sammen, og vasket med natriumbikarbonatoppløsning og vann, og så tørket over natriumsulfat. Etter fordampning av oppløsningsmidlene i vakuum ble residumet utkrystallisert fra heksan, hvorved man fikk 23,4 g 4-fenyl-a-metylstyren, smeltepunkt 116-118°C. A suspension of 42.4 g of 2-(4-biphenylyl)-2-propanol in 100 ml of 4N sulfuric acid and 50 ml of ethanol was boiled under reflux and vigorous stirring for 1.1/2 hours. Then 50 ml of ethanol was added and the mixture was refluxed for a further 2.1/2 hours. After cooling to room temperature, the mixture was poured into ice water and extracted with ether, benzene and chloroform. The organic extracts were combined, and washed with sodium bicarbonate solution and water, and then dried over sodium sulfate. After evaporation of the solvents in vacuo, the residue was crystallized from hexane, whereby 23.4 g of 4-phenyl-a-methylstyrene was obtained, melting point 116-118°C.
Analyse, beregnet for C. _H, .: C, 92,74: H, 7,26 Analysis, calculated for C. _H, .: C, 92.74: H, 7.26
lb 14 lb 14
Funnet: C, 92,45; H, 6,98. Found: C, 92.45; H, 6.98.
Eksempel 11- 21. Example 11-21.
De følgende forbindelser ble fremstilt som angitt i eksempel 10 ved å bruke en passende propanol som utgangsmateriale. 3-fenyltio-a-metylstyren, kokepunkt 113-115°/0,05 mm; = The following compounds were prepared as indicated in Example 10 using an appropriate propanol as starting material. 3-phenylthio-a-methylstyrene, boiling point 113-115°/0.05 mm; =
1,6248 som inneholder 10% av utgangskarbinolen, slik denne kunne måles ved Nmr, fra 2-(3-fenyltio-fenyl)-2-propanol. 1.6248 which contains 10% of the starting carbinol, as this could be measured by Nmr, from 2-(3-phenylthio-phenyl)-2-propanol.
4-fenyltio-ot-metylstyren, kokepunkt 147-167/0,2 mm; n^ 25 = 1,6374, fra 2-(4-fenyltiofenyl)-2-propanol. 4-phenylthio-o-methylstyrene, boiling point 147-167/0.2 mm; n^ 25 = 1.6374, from 2-(4-phenylthiophenyl)-2-propanol.
Analyse, beregnet for C, cH1ylS: C, 79,62;H,6,24. Analysis, calculated for C, cH1ylS: C, 79.62; H, 6.24.
lo 14 laughed 14
Funnet: C, 79,49; H,. 6,64. Found: C, 79.49; H,. 6.64.
4-iso-butyl-a-metylstyren, kokepunkt, 75-100°/0,4 mm; nD 25 = 1,5182, fra 2-(4-iso-butylfenyl)-2-propanol. 4-iso-butyl-a-methylstyrene, boiling point, 75-100°/0.4 mm; nD 25 = 1.5182, from 2-(4-iso-butylphenyl)-2-propanol.
Analyse, beregnet for C^H.^: C, 89,59; H, 10,41 Analysis, calcd for C 2 H 2 : C, 89.59; H, 10.41
Funnet: C, 89,52; H, 10,49 Found: C, 89.52; H, 10.49
4-sec-butyl-a-metylstyren, kokepunkt, 52-53°/0,07 mm; nD<24>= 1,5188, fra 2-(4-sec-butylfenyl)-2-propanol. 4-sec-butyl-α-methylstyrene, bp, 52-53°/0.07 mm; nD<24>= 1.5188, from 2-(4-sec-butylphenyl)-2-propanol.
Analyse, beregnet for C13Hlg: C, 89,59; H, 10,41. Analysis, calcd for C13Hlg: C, 89.59; H, 10.41.
Funnet: C, 89,36; H, 10,43. Found: C, 89.36; H, 10.43.
4-cykloheksyl-a-metylstyren, kokepunkt 122-14 2°/ 4-cyclohexyl-α-methylstyrene, boiling point 122-14 2°/
25 25
0,15 mm; nD = 1,5484, fra 2-(4-cykloheksylfenyl)-2-propanol. Analyse, beregnet for C.,-H0rt: C, 89,94; H, 10,06. 0.15mm; nD = 1.5484, from 2-(4-cyclohexylphenyl)-2-propanol. Analysis, calculated for C.,-H0rt: C, 89.94; H, 10.06.
lo 2U laughed 2U
Funnet: C, 90,15; H, 10,33. Found: C, 90.15; H, 10.33.
3-metyl-4-fenoksy-a-metylstyren,- kokepunkt 125-134°/0,08 mm, nD<25>= 1,5856, fra 2-(3-metyl-4-fenoksyfenyl)-2-propanol. 3-methyl-4-phenoxy-α-methylstyrene, bp 125-134°/0.08 mm, nD<25>= 1.5856, from 2-(3-methyl-4-phenoxyphenyl)-2-propanol.
Analyse, beregnet for C,, E., 0: C, 85,68; H, 7,19. Analysis, calculated for C,, E., 0: C, 85.68; H, 7.19.
lb lb lb lb
Funnet: C, 85,44; H, 7,06 Found: C, 85.44; H, 7.06
3-metoksy-4-fenoksy-a-metylstyren, kokepunkt 157-160°/0,07 mm; nD<25>= 1,5914, fra 2-(3-metoksy-4-fenoksyfenyl)-2-propanol. 3-methoxy-4-phenoxy-α-methylstyrene, boiling point 157-160°/0.07 mm; nD<25>= 1.5914, from 2-(3-methoxy-4-phenoxyphenyl)-2-propanol.
Analyse, beregnet for C.,H1C0_: C, 79,97; H, 6,71 Analysis, calcd for C.,H 1 CO_: C, 79.97; H, 6.71
lb lbZlb lbZ
Funnet: C, 79,75; H, 6,76. . 4-(4-fluorfenyl)-a-metylstyren, smeltepunkt, 127-128°, fra 2- (4 ' -fluorbifenylyl) -^2-propanol. Found: C, 79.75; H, 6.76. . 4-(4-fluorophenyl)-α-methylstyrene, m.p., 127-128°, from 2-(4'-fluorobiphenylyl)-^2-propanol.
Analyse, beregnet for C, 84,87; H, 6,17. Analysis, calculated for C, 84.87; H, 6.17.
Funnet: C, 84,68; H, 6,45. Found: C, 84.68; H, 6.45.
3-fenoksy-ct-metylstyren, kokepunkt, 103-115°/0,08 mm; 3-phenoxy-ct-methylstyrene, bp, 103-115°/0.08 mm;
25 25
nD = 1,5873, fra 2-(3-fenoksyfenyl)-2-propanol. nD = 1.5873, from 2-(3-phenoxyphenyl)-2-propanol.
Analyse, beregnet for ci5Hi4°» c'85,68; H, .6,71. Analysis, calculated for 15H14°» c'85.68; H, .6.71.
Funnet: C, 85,69; H, 6,90. 3- klor-4-allyloksy-a-metylstyren, kokepunkt, 99-105°/0,07 mm; nD<24>= 1,5623, fra 2-(3-klor-4-allyloksyfenyl)-2-propanol. Found: C, 85.69; H, 6.90. 3-chloro-4-allyloxy-a-methylstyrene, bp, 99-105°/0.07 mm; nD<24>= 1.5623, from 2-(3-chloro-4-allyloxyphenyl)-2-propanol.
Analyse, beregnet for c12Hi3Cio: C'69'14'H' 6'29*' P» 7,68. . Funnet: C, 69,23: H, 6,20; 0, 7,85* 4- n-butyl-a-metylstyren, kokepunkt, 84-88°/0,05 mm; nD 21= 1,5182, fra 2-(4-n-butylfenyl)-2-propanol. Analysis, calculated for c12Hi3C10: C'69'14'H' 6'29*' P» 7.68. . Found: C, 69.23: H, 6.20; 0, 7.85* 4- n-butyl-a-methylstyrene, bp, 84-88°/0.05 mm; nD 21 = 1.5182, from 2-(4-n-butylphenyl)-2-propanol.
Analyse, beregnet for C--.H10: e, 89,48; H, 10,48. Analysis, calcd for C--.H10: e, 89.48; H, 10.48.
1 j lo 1 j lo
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NO751753A NO751753L (en) | 1970-11-20 | 1975-05-16 |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9155970A | 1970-11-20 | 1970-11-20 | |
US12923771A | 1971-03-29 | 1971-03-29 | |
NO243371A NO132724C (en) | 1970-11-20 | 1971-06-25 | |
NO751753A NO751753L (en) | 1970-11-20 | 1975-05-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
NO751753L true NO751753L (en) | 1972-05-24 |
Family
ID=27484001
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO751753A NO751753L (en) | 1970-11-20 | 1975-05-16 |
Country Status (1)
Country | Link |
---|---|
NO (1) | NO751753L (en) |
-
1975
- 1975-05-16 NO NO751753A patent/NO751753L/no unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4230862A (en) | Antifertility compounds | |
US3576883A (en) | Alkylidenedithiobisphenols | |
PT84860B (en) | METHOD FOR PREPARING NEW TETRAHYDROFOLANTALEN DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
DD145101A5 (en) | PROCESS FOR THE PREPARATION OF INDA YL DERIVATIVES | |
CA1093087A (en) | Retinoic acid derivatives | |
CA1245663A (en) | 1-nitrogen containing-7-hydroxy-indone derivatives and salts thereof | |
US2771391A (en) | Physiologically active p-alkoxy-beta-piperidinopropiophenones causing cns depressantand anesthetic effects in animals | |
US3427305A (en) | 5 - ((halo/alkoxy)phenyl) - 1 - (p - sulfonamido(phenyl/benzyl)) - 2 - pyrrolepropionic acids | |
NO164348B (en) | ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE ALKENE COMPOUNDS. | |
US3991212A (en) | Anti-inflammatory agents | |
US4590205A (en) | Antiinflammatory and/or analgesic 2,3-diaryl-5-halo thiophenes | |
NO751753L (en) | ||
EP0010361A1 (en) | Bis-imidazoles, their preparation and pharmaceutical compositions containing them | |
EP0087629A2 (en) | Antiinflammatory and/or analgesic 2,3-Diaryl-5-halo thiophenes | |
US2789138A (en) | d-nu-methyl-nu-benzyl-beta-phenyliso-propylamine | |
US4029803A (en) | Method of treatment with 2-iminothiazolidines and thiazolines | |
US4096250A (en) | Tri-substituted phosphinegold(I) 1-thio-β-D-glucopyranosides | |
US4008327A (en) | Tolyloxypivalophenone derivatives | |
US4065503A (en) | P-Phenoxy-alkylphenones and corresponding alcohols | |
US4122191A (en) | Antirhinovirus agents | |
US3979468A (en) | 4'-Chloro-4-ethynylbiphenyl and method of preparing same | |
US3494964A (en) | Alpha-halo-alpha-amino ketones | |
US4171360A (en) | Phosphinegold (I) salts having antiarthritic activity | |
JPS6114141B2 (en) | ||
US3151148A (en) | Cyano stilbene hypocholesterolemic |